http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2135139-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4039cb571ab4b9e8458ca2a21c51ac94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_889928b482bd13e197c3fbf559f13086
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-104
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L26-00
filingDate 1994-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_450609c83d09b990ba83a523ec884a97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_845c6e9eb8fed3a37b9e4eb90fb9b801
publicationDate 1995-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2135139-A1
titleOfInvention Topical antibacterial preparation
abstract ABSTRACT OF THE DISCLOSURE The present invention relates to a topical antibacterial preparation for the treatment of infected hands and for the advancement of their healing. The preparation comprises silver sulfadiazine (SSD) and collagen, in which the ratio of W/W of collagen to SSD ranges from 4 parts collagen to 1 part SSD, to 200 parts collagen to 1 part SSD. The concentration of the SSD is preferably 0.5% to 2.5%, advantageously 1%. The collagen is advantageously native collagen, which may be acid soluble or insoluble, or mixtures thereof. The preparation may comprise an inert excipient, e.g. SiO2, or blood plasma components, peptides, carbo-hydrates.
priorityDate 1993-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID64148
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425183462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID64148
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413

Total number of triples: 36.